Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Guixà González, Ramon ^a   Javanainen, Matti ^b   Gómez Soler, Maricel ^c   Cordobilla, Begoña ^c   Domingo, Joan Carles ^c   Sanz, Ferran ^a   Pastor, Manuel ^a   Ciruela, Francisco ^c,d   Martinez Seara, Hector ^b   Selent, Jana ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF BARCELONA   (Spain)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; DOCOSAHEXAENOIC ACID; DOPAMINE 2 RECEPTOR; FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; PROTEIN AGGREGATE;

CELL MEMBRANE; CELL SURVIVAL; DIFFUSION; DRUG EFFECTS; HEK293 CELL LINE; HUMAN; KINETICS; METABOLISM; MOLECULAR DYNAMICS; PROBABILITY; PROTEIN MULTIMERIZATION; TIME FACTOR;

CELL MEMBRANE; CELL SURVIVAL; DIFFUSION; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; HEK293 CELLS; HUMANS; KINETICS; MOLECULAR DYNAMICS SIMULATION; PHOSPHOLIPIDS; PROBABILITY; PROTEIN AGGREGATES; PROTEIN MULTIMERIZATION; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 84955489920     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19839     Document Type: Article

References (64)

1. Taha, A. Y., Cheon, Y., Ma, K., Rapoport, S. I. & Rao, J. S. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J. Psychiat. Res. 47, 636-643 (2013).
2. Martín, V. et al. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J. Alzheimers Dis. 19, 489-502 (2010).
3. Fabelo, N. et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol. Med. 17, 1107-1118 (2011).
4. Innis, S. M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 1237, 35-43 (2008).
5. Calon, F. & Cole, G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostag. Leukotr. Ess. 77, 287-293 (2007).
6. Tanaka, K., Farooqui, A. A., Siddiqi, N. J., Alhomida, A. S. & Ong, W.-Y. Effects of Docosahexaenoic Acid on Neurotransmission. Biomol. Ther. 20, 152-157 (2012).
7. Jeffrey, B. G., Weisinger, H. S., Neuringer, M. & Mitchell, D. C. The role of docosahexaenoic acid in retinal function. Lipids 36, 859-871 (2001).
8. Pinot, M. et al. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins. Science 345, 693-697 (2014).
9. Wassall, S. R. & Stillwell, W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. BBABiomembranes 1788, 24-32 (2009).
10. Salem, N., Litman, B., Kim, H. Y. & Gawrisch, K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945-959 (2001).
11. Akter, K. et al. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia. J. Clin. Pharm. Ther. 37, 132-139 (2012).
12. Bousquet, M., Calon, F. & Cicchetti, F. Impact of omega-3 fatty acids in Parkinson's disease. Ageing Res. Rev. 10, 453-463 (2011).
13. Mondal, S., Khelashvili, G., Johner, N. & Weinstein, H. How The Dynamic Properties And Functional Mechanisms Of GPCRs Are Modulated By Their Coupling To The Membrane Environment, vol. 796 of Advances in Experimental Medicine and Biology (Springer Netherlands, 2014).
14. Gawrisch, K., Soubias, O. & Mihailescu, M. Insights from biophysical studies on the role of polyunsaturated fatty acids for function of G-protein coupled membrane receptors. Prostag. Leukotr. Ess. 79, 131-134 (2008).
15. Catapano, L. A. & Manji, H. K. G protein-coupled receptors in major psychiatric disorders. Biochim. Biophys. Acta 1768, 976-93 (2007).
16. Mitchell, D. C., Niu, S.-L. & Litman, B. J. Enhancement of G protein-coupled signaling by DHA phospholipids. Lipids 38, 437-443 (2003).
17. Mitchell, D. C., Straume, M. & Litman, B. J. Role of sn-1-saturated, sn-2-polyunsaturated phospholipids in control of membrane receptor conformational equilibrium: effects of cholesterol and acyl chain unsaturation on the metarhodopsin I 虠 metarhodopsin II equilibrium. Biochemistry-US 31, 662-670 (1992).
18. Litman, B. J., Niu, S. L., Polozova, A. & Mitchell, D. C. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J. Mol. Neurosci. 16, 237-242 (2001).
19. Feller, S. E., Gawrisch, K. & Woolf, T. B. Rhodopsin exhibits a preference for solvation by polyunsaturated docosohexaenoic acid. J. Am. Chem. Soc. 125, 4434-4435 (2003).
20. Grossfield, A., Feller, S. E. & Pitman, M. C. Contribution of omega-3 fatty acids to the thermodynamics of membrane protein solvation. J. Phys. Chem. B 110, 8907-8909 (2006).
21. Milligan, G. The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization. Mol. Pharmacol. 84, 158-169 (2013).
22. Ferré, S., Ciruela, F., Woods, A. S., Lluis, C. & Franco, R. Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 30, 440-446 (2007).
23. Guixà-González, R., Bruno, A., Marti-Solano, M. & Selent, J. Crosstalk within GPCR heteromers in schizophrenia and Parkinson's disease: physical or just functional? Curr. Med. Chem. 19, 1119-1134 (2012).
24. Perreault, M. L., Hasbi, A., O'Dowd, B. F. & George, S. R. Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacol. 39, 156-168 (2014).
25. Guidolin, D., Agnati, L. F., Marcoli, M., Borroto-Escuela, D. O. & Fuxe, K. G-protein-coupled receptor type a heteromers as an emerging therapeutic target. Expert Opin. Ther. Tar. 1-19 (2015).
26. 2 receptor heteromers. J. Med. Chem. 52, 5590-5602 (2009).
27. 2 receptors for the potential treatment of parkinson's disease. J. Med. Chem. 58, 718-738 (2015).
28. 2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Neurochem. 88, 726-734 (2004).
29. 2 receptor dimers in human and rat brain. FEBS Lett. 441, 383-386 (1998).
30. 2A receptors assemble into higher-order oligomers at the plasma membrane. FEBS Lett. 582, 3985-3990 (2008).
31. 2 receptors form higher order oligomers at physiological expression levels. EMBO J. 27, 2293-2304 (2008).
32. 2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism R. D. 10, 265-271 (2004).
33. 2A receptors: Past, present and future trends for the treatment of parkinson's disease. Curr. Med. Chem. 21, 3188-3210 (2014).
34. 2 receptors and their interactions in Parkinson's disease. Movement Disord. 22, 1990-2017 (2007).
35. Pou, C., La Cour, C. M., Stoddart, L. a., Millan, M. J. & Milligan, G. Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. J. Biol. Chem. 287, 8864-8878 (2012).
36. Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P. & de Vries, A. H. The MARTINI force field: coarse grained model for biomolecular simulations. J. Phys. Chem. B 111, 7812-7824 (2007).
37. Monticelli, L. et al. The MARTINI Coarse-grained force field: extension to proteins. J. Chem. Theory Comput. 4, 819-834 (2008).
38. Javanainen, M. Universal method for embedding proteins into complex lipid bilayers for molecular dynamics simulations. J. Chem. Theory Comput. 10, 2577-2582 (2014).
39. 2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278, 46741-46749 (2003).
40. Casado, V. et al. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods 5, 727-733 (2008).
41. Romero-Fernandez, W. et al. Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family. Biochem. Biophys. Res. Co. 409, 764-768 (2011).
42. Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830-7843 (2010).
43. Lim, J. B., Rogaski, B. & Klauda, J. B. Update of the cholesterol force field parameters in CHARMM. J. Phys. Chem. B 116, 203-210 (2012).
44. MacKerell, A. & Bashford, D. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 5647, 3586-3616 (1998).
45. Harvey, M., Giupponi, G. & Fabritiis, G. ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J. Chem. Theory Comput. 5, 1-9 (2009).
46. Ayoub, M. A. & Pfleger, K. D. G. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr. Opin. Pharmacol. 10, 44-52 (2010).
47. Lan, T.-H. et al. Bret evidence that β2 adrenergic receptors do not oligomerize in cells. Sci. Rep. 5 (2015).
48. 4 homoand heterodimers. J. Biol. Chem. 280, 9895-9903 (2005).
49. 1 muscarinic receptor. Biol. Cell 102, 409-420 (2010).
50. Periole, X., Knepp, A., Sakmar, T. P., Marrink, S. J. & Huber, T. Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. J. Am. Chem. Soc. 134, 10959-10965 (2012).
51. Mondal, S. et al. Membrane driven spatial organization of GPCRs. Sci. Rep. 3, 2909 (2013).
52. Ghosh, A., Sonavane, U. & Joshi, R. Multiscale modelling to understand the self-assembly mechanism of human β2-adrenergic receptor in lipid bilayer. Comput. Biol. Chem. 48, 29-39 (2014).
53. Provasi, D., Boz, M. B., Johnston, J. M., Filizola, M. & MacKerell, A. Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association. PLoS Comp. Biol. 11, e1004148-e1004148 (2015).
54. Javanainen, M. et al. Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes. Faraday Discuss. 161, 397-417 (2013).
55. Niemelä, P. et al. Membrane proteins diffuse as dynamic complexes with lipids. J. Am. Chem. Soc. 132, 7574-7575 (2010).
56. Risselada, H. J. & Marrink, S. J. The molecular face of lipid rafts in model membranes. P. Natl. Acad. Sci. USA 105, 17367-17372 (2008).
57. Domański, J., Marrink, S. J. & Schäfer, L. V. Transmembrane helices can induce domain formation in crowded model membranes. BBA-Biomembranes 1818, 984-994 (2012).
58. Stark, A. C., Andrews, C. T. & Elcock, A. H. Toward optimized potential functions for protein-protein interactions in aqueous solutions: osmotic second virial coefficient calculations using the martini coarse-grained force field. J. Chem. Theory Comput. 9, 4176-4185 (2013).
59. de Jong, D. H. et al. Improved parameters for the martini coarse-grained protein force field. J. Chem. Theory Comput. 9, 687-697 (2012).
60. Polozova, A. & Litman, B. J. Cholesterol dependent recruitment of di22:6-PC by a G protein-coupled receptor into lateral domains. Biophys. J. 79, 2632-2643 (2000).
61. Feller, S. E., Gawrisch, K. & MacKerell, A. D. Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J. Am. Chem. Soc. 124, 318-326 (2002).
62. Pitman, M. C., Grossfield, A., Suits, F. & Feller, S. E. Role of cholesterol and polyunsaturated chains in lipid-protein interactions molecular dynamics simulation of rhodopsin in a realistic membrane environment. J. Am. Chem. Soc. 127, 4576-4577 (2005).
63. Schöneberg, J., Heck, M., Hofmann, K. P. & Noé, F. Explicit Spatiotemporal Simulation of Receptor-G Protein Coupling in Rod Cell Disk Membranes. Biophys. J. 107, 1042-1053 (2014).
64. Gunkel, M., Schöneberg, J., Alkhaldi, W., Irsen, S., Noé, F. & Al-Amoudi, A. Higher-order architecture of rhodopsin in intact photoreceptors and its implication for phototransduction kinetics. Structure 23, 628-638 (2015).